Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
- 25 March 2018
- journal article
- research article
- Published by Elsevier BV in The Lancet HIV
- Vol. 5 (5), e211-e220
- https://doi.org/10.1016/s2352-3018(18)30021-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- In VitroCharacterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase InhibitorAntimicrobial Agents and Chemotherapy, 2014
- Characterization of HIV-1 Drug Resistance Development Through Week 48 in Antiretroviral Naive Subjects on Rilpivirine/Emtricitabine/Tenofovir DF or Efavirenz/Emtricitabine/Tenofovir DF in the STaR Study (GS-US-264-0110)JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent TrialsAIDS Research and Treatment, 2014
- Rilpivirine: drug profile of a second-generation non-nucleoside reverse transcriptase HIV-inhibitorExpert Review of Anti-infective Therapy, 2013
- Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapyAIDS, 2013
- Impact of baseline HIV‐1 RNA levels on initial highly active antiretroviral therapy outcome: a meta‐analysis of 12,370 patients in 21 clinical trials*HIV Medicine, 2012
- Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trialThe Lancet, 2011
- Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trialThe Lancet, 2011
- Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48AIDS, 2008
- Comparative analysis of two ratesStatistics in Medicine, 1985